BIOAVAILABILITY AND ACCEPTABILITY OF A DISPERSIBLE FORMULATION OF LEVODOPA-BENSERAZIDE IN PARKINSONIAN-PATIENTS WITH AND WITHOUT DYSPHAGIA

被引：25
|
作者：
BAYER, AJ
DAY, JJ
FINUCANE, P
PATHY, MSJ
机构：
来源：
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 1988年 / 13卷 / 03期
关键词：
D O I：
10.1111/j.1365-2710.1988.tb00179.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：191 / 194
页数：4
相关论文
共 50 条
  • [1] LEVODOPA-BENSERAZIDE (MADOPAR) COMBINATION THERAPY IN ELDERLY PATIENTS WITH PARKINSONISM
    WILLIAMS, BO
    CARLYLE, D
    CURRENT MEDICAL RESEARCH AND OPINION, 1979, 6 (01) : 1 - 7
  • [2] DOSAGE FORM DESIGN FOR IMPROVEMENT OF BIOAVAILABILITY OF LEVODOPA .2. BIOAVAILABILITY OF MARKETED LEVODOPA PREPARATIONS IN DOGS AND PARKINSONIAN-PATIENTS
    SASAHARA, K
    NITANAI, T
    HABARA, T
    MORIOKA, T
    NAKAJIMA, E
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (03) : 261 - 265
  • [3] RESPONSE TO BRIEF LEVODOPA INFUSIONS IN PARKINSONIAN-PATIENTS WITH AND WITHOUT MOTOR FLUCTUATIONS
    GANCHER, ST
    NUTT, JG
    WOODWARD, W
    NEUROLOGY, 1988, 38 (05) : 712 - 716
  • [4] INCREASED DOSAGE OF CARBIDOPA IN PARKINSONIAN-PATIENTS ON LOW CARBIDOPA-LEVODOPA REGIMEN - EFFECT ON LEVODOPA BIOAVAILABILITY
    CONTIN, M
    RIVA, R
    MARTINELLI, P
    PROCACCIANTI, G
    BARUZZI, A
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (01) : 75 - 81
  • [5] PHARMACODYNAMICS OF THE HYPOTENSIVE EFFECT OF LEVODOPA IN PARKINSONIAN-PATIENTS
    IRWIN, RP
    NUTT, JG
    WOODWARD, WR
    GANCHER, ST
    CLINICAL NEUROPHARMACOLOGY, 1992, 15 (05) : 365 - 374
  • [6] RESPONSE TO A STANDARD ORAL LEVODOPA TEST IN PARKINSONIAN-PATIENTS WITH AND WITHOUT MOTOR FLUCTUATIONS
    CONTIN, M
    RIVA, R
    MARTINELLI, P
    PROCACCIANTI, G
    CORTELLI, P
    AVONI, P
    BARUZZI, A
    CLINICAL NEUROPHARMACOLOGY, 1990, 13 (01) : 19 - 28
  • [7] CONTROLLED-RELEASE LEVODOPA BENSERAZIDE (MADOPAR HBS) - CLINICAL OBSERVATIONS AND LEVODOPA AND DOPAMINE PLASMA-CONCENTRATIONS IN FLUCTUATING PARKINSONIAN-PATIENTS
    CEBALLOSBAUMANN, AO
    VONKUMMER, R
    ECKERT, W
    WEICKER, H
    JOURNAL OF NEUROLOGY, 1990, 237 (01) : 24 - 28
  • [8] LEVODOPA PHARMACOKINETICS AND PHARMACODYNAMICS IN FLUCTUATING PARKINSONIAN-PATIENTS
    NUTT, JG
    WOODWARD, WR
    NEUROLOGY, 1986, 36 (06) : 739 - 744
  • [9] NOMIFENSINE - EFFECT IN PARKINSONIAN-PATIENTS NOT RECEIVING LEVODOPA
    PARK, DM
    FINDLEY, LJ
    HANKS, G
    SANDLER, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1981, 44 (04) : 352 - 354
  • [10] Clinical efficacy and tolerability of a new levodopa/benserazide dual-release formulation in parkinsonian patients
    Ghika, J
    Gachoud, JP
    Gasser, U
    BeckFohn, M
    Burgunder, JM
    Corbat, F
    Curchod, J
    Dessibourg, CA
    Dufresne, JJ
    Ferel, D
    Ferrazzini, M
    Friedli, P
    Gschwend, G
    Hess, C
    HewWinzeler, AM
    Jenik, F
    Jenzer, G
    Justafre, JC
    Kasper, U
    Ludin, HP
    Markoff, R
    Meienberg, O
    Meyer, C
    Nancoz, RB
    Rast, N
    Riederer, E
    Rouselle, J
    Steck, A
    Stockli, HR
    Tosi, C
    Tscholl, RJ
    CLINICAL NEUROPHARMACOLOGY, 1997, 20 (02) : 130 - 139
12345